MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Suppression of dyskinesia in Parkinson’s disease by electrical stimulation of dorsal subthalamic nucleus tissue

H.A.C. Wark, G.H. Duffley, C.R. Butson, L.E. Schrock (Salt Lake City, UT, USA)

Meeting: 2016 International Congress

Abstract Number: 1301

Keywords: Deep brain stimulation (DBS), Dyskinesias, Neurostimulation, Parkinsonism

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Neuroimaging and neurophysiology

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: The objectives of this study were to investigate suppression of dyskinesia in Parkinson’s disease (PD) patients who had previously undergone deep brain stimulation (DBS) surgery by delivering electrical stimulation dorsal to the subthalamic nucleus (STN), and secondly, to determine the underlying neural circuits that when stimulated, suppressed dyskinesia.

Background: Although DBS may significantly reduce dyskinesia in most PD patients following surgery, some patients either continue to have or develop new dyskinesia symptoms. Recent reports indicate delivery of stimulation via more dorsal STN DBS contacts may decrease the severity of dyskinesia. It is unknown what neuronal structures or tracts that once stimulated, are responsible for suppression of dyskinesia symptoms.

Methods: Retrospective patient chart data was reviewed for 15 PD patients with bilateral STN DBS who began to experience levodopa-induced dyskinesia. UPDRS-IV dyskinesia sub-scores were used to quantify clinical responses and significance was determined (two-tailed paired t-test). Levodopa equivalent daily dosages (LEDD) before and after the new stimulation settings were analyzed for significant changes. Stimulation was delivered via proximal DBS contacts using variable parameters (monopolar, bipolar, simultaneous or interleaved) depending on the patients’ clinical response.

Results: Dyskinesia scores significantly (p < 0.0001) decreased in each patient after the addition of electrical stimulation to one or more of the dorsal contacts (mean±std of scores: pre stim = 6.67±3.43; post stim = 1.00±1.32; n=9 patients). Dyskinesia scores remained decreased following the addition of the dorsal contact stimulation, regardless of when the score was obtained relative to medication dosing. LEDD did not significantly change after new DBS settings (p = 0.049; n=15). Future analyses will examine the volume of tissue activated in each patient in order to identify the underlying circuits responsible for dyskinesia suppression with dorsal STN DBS.

Conclusions: In PD, the development of dyskinesia may be difficult to treat and such movements can be disturbing to the patients’ quality of life. By using current steering techniques, physicians may now be able to target dorsal STN neural tissue to help decrease dyskinesia in PD patients with STN DBS.

To cite this abstract in AMA style:

H.A.C. Wark, G.H. Duffley, C.R. Butson, L.E. Schrock. Suppression of dyskinesia in Parkinson’s disease by electrical stimulation of dorsal subthalamic nucleus tissue [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/suppression-of-dyskinesia-in-parkinsons-disease-by-electrical-stimulation-of-dorsal-subthalamic-nucleus-tissue/. Accessed May 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/suppression-of-dyskinesia-in-parkinsons-disease-by-electrical-stimulation-of-dorsal-subthalamic-nucleus-tissue/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley